Nice find - especially to get a mention for PYC.
I think Genetech (Roche) is next years story (from memory they get the first round of info before the year is out so allow another 3-9 months to review) but I don't rule out further interest from other areas of Genetech eg in the oncology area. If any of those milestones drop then it will scale up pretty quickly and I suspect with cash in the bank any new deals we sign will be of greater value than those of the past ( not just cause the USD is stronger).
Plenty of other things to watch for as we have discussed before.
Roche buys GeneWeave to boost antibiotics portfolio, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.005(0.40%) |
Mkt cap ! $731.9M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.29 | $1.19 | $429.5K | 349.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4016 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |